Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Phreesia General Counsel Sells Shares Under 10b5-1 Plan

Allison C. Hoffman, General Counsel and Secretary of Phreesia, Inc. (NYSE:PHR), filed a Form 4 on September 22, 2026, reporting two transactions in the company's common stock dated September 18 and September 21, 2026.

Vinay Lochav | 22 September 2026

Phreesia SVP Amy VanDuyn Reports RSU Tax Withholding

Amy Beth VanDuyn, Senior Vice President of Human Resources at Phreesia, Inc., filed a Form 4 on September 22, 2026, disclosing a share disposition on September 18, 2026, connected to the settlement of restricted stock units.

Aakashdeep | 22 September 2026

Genesco CFO Buys 295 Shares of Common Stock

Jonathan M. Collins, SVP Finance and CFO of Genesco Inc., filed a Form 4 on September 22, 2026, disclosing the open-market purchase of 295 shares of Genesco common stock on September 21, 2026.

Vinay Lochav | 22 September 2026

Groupon Chief Accounting Officer Reports RSU Vesting

Kyle Netzly, Chief Accounting Officer of Groupon, Inc., filed a Form 4 on September 22, 2026, disclosing the vesting of restricted stock units and a related tax withholding transaction that occurred on September 18, 2026.

Anjali Anand | 22 September 2026

BioNTech CEO Ugur Sahin Sells 79,000 Ordinary Shares

Ugur Sahin, Chief Executive Officer and 10% owner of BioNTech SE (NASDAQ:BNTX), filed a Form 4 on September 22, 2026, reporting the sale of 79,000 ordinary shares across two transactions on September 21 and September 22, 2026, pursuant to a pre-established Rule 10b5-1 trading …

Aditi Sarkar | 22 September 2026

DigitalOcean CEO Sells 11,394 Shares Under 10b5-1 Plan

DigitalOcean Holdings, Inc. Chief Executive Officer T Padmanabhan Srinivasan filed a Form 4 on September 22, 2026, disclosing the sale of 11,394 shares of common stock on September 21, 2026.

Manish Choudhary | 22 September 2026

Cytokinetics EVP Exercises Options and Sells 3,500 Shares

Fady Ibraham, Executive Vice President of Research and Development at Cytokinetics Inc, filed a Form 4 on September 22, 2026, reporting the exercise of stock options and the same-day sale of 3,500 shares of common stock pursuant to a Rule 10b5-1 plan.

Aakashdeep | 22 September 2026

Mink Brook Asset Management Adds DLH Holdings Shares

Mink Brook Asset Management LLC filed a Form 4 with the SEC on September 22, 2026, reporting open-market purchases of DLH Holdings Corp. common stock on September 21 and September 22, 2026, through its managed fund Mink Brook Partners LP.

Anjali Anand | 22 September 2026

Aura Minerals Director Reports BDR-to-Share Conversion

Bruno Sousa Mauad, a director of Aura Minerals Inc. (NASDAQ:AUGO), filed a Form 4 on September 22, 2026, disclosing transactions on September 21, 2026, in which Brazilian Depositary Receipts held indirectly through Kapitalo Investimentos were converted into common shares.

Shwetambri Chauhan | 22 September 2026

Structure Therapeutics CMO Reports Share Transactions

Blas Coll Crespo, Chief Medical Officer of Structure Therapeutics Inc. (NASDAQ:GPCR), filed a Form 4 on September 22, 2026, disclosing share withholding, conversion, and sale transactions in ordinary shares and American Depositary Shares dated September 18 and September 21, 2026.

Manish Choudhary | 22 September 2026
Support

Hi! How can we help you today?

Loading…